Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 1021-1025

  Hohberg, Clothilde ^a   Forst, Thomas ^a,b   Larbig, Martin ^c   Safinowski, Michael ^a   Diessel, Stefan ^a   Hehenwarter, Silvia ^a   Weber, Matthias M ^b   Schöndorf, Thomas ^a   Pfützner, Andreas ^a  

^a Institute for Clinical Research and Development   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Sanofi   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; FATTY ACID; GELATINASE B; GLUCOSE; HUMAN INSULIN; INSULIN GLULISINE; INTERLEUKIN 18; N(G),N(G) DIMETHYLARGININE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROINSULIN; 3-NITROTYROSINE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; TYROSINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LASER DOPPLER FLOWMETRY; LIPOPROTEIN BLOOD LEVEL; MALE; MICROVASCULARIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; TEST MEAL; BLOOD; BLOOD FLOW VELOCITY; CROSSOVER PROCEDURE; DRUG EFFECT; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; AGED; BLOOD FLOW VELOCITY; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; PATIENT SELECTION; POSTPRANDIAL PERIOD; PROINSULIN; TYROSINE;

EID: 48649083056     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2185     Document Type: Article

References (26)

1. Skilton MR, Lai NT, Griffiths KA, Molyneaux LM, Yue DK, Sullivan DR, Celermajer DS: Meal-related increases in vascular reactivity are impaired in older and diabetic adults. Am J Physiol Heart Circ Physiol 288:H1404-H1410, 2005
2. Forst T, Kunt T, Pohlmann T, Goitom K, Löbig M, Engelbach M, Beyer J, Pfutzner A: Microvascular skin blood flow following the ingestion of 75g glucose in healthy individuals. Exp Clin Endocrinol Diabetes 106:453-458, 1998
3. Forst T, Forst S, Strunk K, Lobig M, Welter K, Kazda C, Pfutzner A: Impact of insulin on microvascular blood flow and endothelial cell function. J Diabetes Complicat 19:128-132, 2005
4. Scognamiglio R, Negut C, De Kreutzen- berg SV, Tiengo A, Avogaro A: Postprandial myocardial perfusion in healthy subjects and type 2. Circulation 112:179-184, 2005
5. Scognamiglio R, Negut C, De Kreutzen- berg SV, Tiengo A, Avogaro A: Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care 29:95-100, 2006
6. Williams SB, Cusco JA, Roddy MA, John- stone MT, Creager MA: - Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27:567-574, 1996
7. Mather K, Anderson TJ, Verma S: Insulin action in the vasculature: physiology and pathophysiology. J Vasc Res 38:415-422, 2001
8. Forst T, Pfutzner A, Kunt T, Pohlmann T, Schenk U, Bauersachs R, Kustner E, Beyer J: Skin microcirculation in patients with type I with and without neuropathy after neurovascular stimulation. Clin Sci 94:255-261, 1998
9. Kubli S, Waeber B, Dalle-Ave A, Feihl F: Reproducibility of laser Doppler imaging of skin blood flow. J Cardiovasc Pharmacol 36:640-648, 2000
10. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M: Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2. J Clin Endocrinol Metab 91:813-819, 2006
11. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C: Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16: 212-218, 1999
12. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E: Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25:1439-1443, 2002
13. Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P: Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities. Am J Clin Nutr 80:51-57, 2004
14. Forst T, Pohlmann T, Kazda Ch, Welter K, Langer F, Forst S, Pfutzner A: The impact of insulin lispro and regular insulin on postprandial endothelial function and microvascular blood flow in type 1 diabetic patients (Abstract). Diabetes 51 (Suppl. 2):A292, 2003
15. Chaudhuri A, Janicke D, Wilson MF, Tri- pathy D, Garg R, Bandyopadhyay A, Cali- eri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P: Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109:849-854, 2004
16. Ceriello A: The emerging role of postprandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 15:188-193, 1998
17. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T: Endogenous nitric oxide synthase inhibitor. Circulation 99:1141-1146, 1999
18. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420-1426, 2002
19. Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, Bryant TA, Chen NT, Torres-Tamayo M, Ramasamy R, Ber- glund L, Ginsberg HN, Homma S, Cannon PJ: Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function. Arterioscler Thromb Vasc Biol 20:2039-2044, 2000
20. Forst T, Hohberg C, Fuellert SD, Lubben G, Konrad T, Lobig M, Weber MM, Sa- chara C, Gottschall V, Pfutzner A: Pharmacological PPARgamma stimulation in contrast to beta cell results in an improvement in adiponectin. Horm Metab 37:521-527, 2005
21. Haffner SM, D'Agostino R, Mykkanen L, Hales CN, Savage PJ, Bergman RN, O'Leary D, Rewers M, Selby J, Tracy R, Saad MF: Proinsulin and insulin concentrations in relation to carotid wall thickness. Stroke 29:1498-1503, 1998
22. Panahloo A, Mohamed-Ali V, Andres C, Denver AE, Yudkin JS: Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors. Metab 47:637-643, 1998
23. Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B: Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care 24: 1240 -1247, 2001
24. Alssema M, Dekker JM, Nijpels G, Ste- houwer CD, Bouter LM, Heine RJ: Proin- sulin concentration is an independent predictor of all-cause and cardiovascular mortality. Diabetes Care 28:860 -865, 2005
25. Zethelius B, Lithell H, Hales CN, Berne C: Insulin sensitivity, proinsulin and insulin as predictors of heart disease. Int J Obes Relat Metab Disord 48:862-867, 2005
26. Forst T, Pfutzner A, Lubben G, Weber M, Marx N, Karagiannis E, Koehler C, Baure- cht W, Hohberg C, Hanefeld M: Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adi- ponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk-the PIOSTAT Study. Metab Clin Exp 56:491-496, 2007